PUBLICATIONS · 8655368
Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Int J Radiat Oncol Biol Phys
- Publication date
- 1996 Jun 1
- First author
- International Nasopharynx Cancer Study Group
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- International Nasopharynx Cancer Study Group
- type
- CollectiveName
- name
- VUMCA I Trial
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- International Nasopharynx Cancer Study Group
- type
- CollectiveName
- name
- VUMCA I Trial
- type
- CollectiveName
- bibliography ids
- nci-bib-1793139cb203e7346acaaaca
- book metadata
- content sha256
- 938fe4f8139993f4735f63c45c8af90ebdca525b15893bac9f24fee422b4b6a2
- document type
- citation
- dois
- 10.1016/s0360-3016(96)80007-1
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:8655368
- immutable id
- pubmed:8655368@938fe4f8139993f4735f63c45c8af90ebdca525b15893bac9f24fee422b4b6a2
- journal
- abbreviation
- Int J Radiat Oncol Biol Phys
- issn electronic
- Source null
- issn print
- 0360-3016
- issue
- 3
- name
- International journal of radiation oncology, biology, physics
- nlm unique id
- 7603616
- pages
- 463-9
- volume
- 35
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 8655368
- provenance
- batch id
- 2752791f8cc3526b9192
- provider
- NCBI PubMed ESummary
- record sha256
- 1fce0a0c2bd61c445d8d61a8b4b9144f32dbbbf2ff7ad7f0b05cfad464193d18
- response sha256
- 8db42d042a938e99e944b9e6af6caf1dd877725c05485e70efac12add1ee08e9
- retrieved at
- 2026-09-09T23:45:25.088603+00:00
- publication date
- display
- 1996 Jun 1
- precision
- day
- year
- 1996
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/8655368/
- title
- Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
Preserved source evidence · Not medical advice
Triangle